Blocknomi
Key Takeaways Shares of Immutep skyrocketed more than 101% following FDA Orphan Drug Designation approval for eftilagimod alfa (efti). The designation applies to soft tissue sarcoma treatment, a rare form…
Related articles
-
35% of European investors would switch banks for crypto access: survey
Crypto.News Published 22.04.2026 08:03
-
OKX Spotlights XRP in Recent Cryptic Post
The Crypto Basic Published 21.04.2026 09:55
-
Bitcoin bull run ‘still too early’ to call as demand lags exiting capital: Analyst
Cointelegraph Published 16.04.2026 16:55
-
Tempo Launches Private Stablecoin Zones for Enterprise Payroll and Treasury Settlements
Bitcoin.com Published 18.04.2026 03:05
-
Bitcoin Up 24% From February Lows, But Breakout in Doubt
CryptoPotato Published 20.04.2026 16:05
-
Forget stablecoin yield, how does the CLARITY Act treat DeFi?
Cointelegraph Published 16.04.2026 13:20
-
XRP Ledger Gains Ground, Surpassing Solana In RWA Space – Pundit Shares
Bitcoinist Published 22.04.2026 00:30
-
Ethereum Foundation-funded project exposes 100 DPRK developers operating in crypto
Crypto.News Published 17.04.2026 08:13